Breaking News - The Fly

Open Search

CSTL

Castle Biosciences

$

()

Castle Biosciences: DecisionDx -Melanoma can precise predict SLN positivity risk

CSTL

9/11/2024 - 07:06am

Castle Biosciences: New study shows DecisionDx-SCC test benefits SCC patients

CSTL

9/5/2024 - 07:08am

Castle Biosciences management to meet virtually with Lake Street

CSTL

8/28/2024 - 04:55am

Castle Biosciences management to meet virtually with Lake Street

CSTL

8/21/2024 - 11:42am

Castle Biosciences price target raised by $3 at Baird, here's why

CSTL

8/6/2024 - 06:38am

Closing Bell Movers: Lumen surges after securing $5B in new business

EVER , CSTL , RXST

…

8/5/2024 - 18:21pm

Castle Biosciences raises FY24 revenue view to $275M-$300M, consensus $260.39M

CSTL

8/5/2024 - 16:16pm

Castle Biosciences reports Q2 EPS 31c vs (70c) last year

CSTL

8/5/2024 - 16:15pm

Canaccord recommends buying Castle Biosciences on weakness after MolDX news

CSTL

7/5/2024 - 12:54pm

Castle MolDX update doesn't impact current Dx-SCC Medicare coverage, says Baird

CSTL

7/5/2024 - 11:21am

Castle Biosciences downside risk 'limited' on MolDx decision, says Leerink

CSTL

7/5/2024 - 11:12am

Castle Biosciences slides after MolDX determination on carcinoma test

CSTL

7/5/2024 - 10:51am

Castle Biosciences announces latest AGA guideline on NDBE

CSTL

6/24/2024 - 07:03am

Castle Biosciences reports inducement grants under Nasdaq rule

CSTL

6/20/2024 - 07:00am

Castle Biosciences publishes study on DecisionDx in SCC patients

CSTL

5/29/2024 - 16:33pm